Fibrinogen αC-subregions critically contribute blood clot fibre growth, mechanical stability and resistance to fibrinolysis

  1. Helen McPherson
  2. Cedric Duval
  3. Stephen R Baker
  4. Matthew S Hindle
  5. Lih T Cheah
  6. Nathan L Asquith
  7. Marco M Domingues
  8. Victoria C Ridger
  9. Simon DA Connell
  10. Khalid Naseem
  11. Helen Philippou
  12. Ramzi A Ajjan
  13. Robert AS Ariens  Is a corresponding author
  1. University of Leeds, United Kingdom
  2. Wake Forest University, United States
  3. Harvard Medical School, United States
  4. Universidade de Lisboa, Portugal
  5. University of Sheffield, United Kingdom
  6. University of Leeds, United States

Abstract

Fibrinogen is essential for blood coagulation. The C-terminus of the fibrinogen α-chain (αC-region) is composed of an αC-domain and αC-connector. Two recombinant fibrinogen variants (α390 and α220) were produced to investigate the role of subregions in modulating clot stability and resistance to lysis. The α390 variant, truncated before the αC-domain, produced clots with a denser structure and thinner fibres. In contrast, the α220 variant, truncated at the start of the αC-connector, produced clots that were porous with short, stunted fibres and visible fibre ends. These clots were mechanically weak and susceptible to lysis. Our data demonstrate differential effects for the αC-subregions in fibrin polymerisation, clot mechanical strength, and fibrinolytic susceptibility. Furthermore, we demonstrate that the αC-subregions are key for promoting longitudinal fibre growth. Together, these findings highlight critical functions of the αC-subregions in relation to clot structure and stability, with future implications for development of novel therapeutics for thrombosis.

Data availability

The source data for Figures 1 B-F, figure 2 B and D, figure 3 B, figure 4, figure 5 B, C and D and figure 6 A-C and D-F and supplementary Figures 1 supplement 1, figures 4 supplement 1 and figures 5 supplement 1 and 2 and figures 6 supplement 1 are made available as separate source data files.

Article and author information

Author details

  1. Helen McPherson

    Discovery and Translational Science Department, Leeds Institute of Cariovasular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3519-498X
  2. Cedric Duval

    Discovery and Translational Science Department, Leeds Institute of Cariovasular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  3. Stephen R Baker

    Department of Physics, Wake Forest University, Winston Salem, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3147-4925
  4. Matthew S Hindle

    Discovery and Translational Science Department, Leeds Institute of Cariovasular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  5. Lih T Cheah

    Discovery and Translational Science Department, Leeds Institute of Cariovasular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  6. Nathan L Asquith

    Division of Hematology, Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Marco M Domingues

    Instituto de Medicina Molecular - João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal
    Competing interests
    The authors declare that no competing interests exist.
  8. Victoria C Ridger

    Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  9. Simon DA Connell

    Molecular and Nanoscale Physics Group, University of Leeds, Leeds, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Khalid Naseem

    Discovery and Translational Science Department, University of Leeds, Leeds, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  11. Helen Philippou

    Discovery and Translational Science Department, Leeds Institute of Cariovasular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  12. Ramzi A Ajjan

    Discovery and Translational Science Department, Leeds Institute of Cariovasular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1636-3725
  13. Robert AS Ariens

    Discovery anTranslational Science Department, University of Leeds, Leeds, United Kingdom
    For correspondence
    R.A.S.Ariens@leeds.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6310-5745

Funding

British Heart Foundation (RG/13/3/30104)

  • Helen McPherson
  • Cedric Duval
  • Stephen R Baker
  • Marco M Domingues
  • Victoria C Ridger
  • Simon DA Connell
  • Helen Philippou
  • Ramzi A Ajjan
  • Robert Ariens

British Heart Foundation (RG/18/11/34036)

  • Helen McPherson
  • Cedric Duval
  • Stephen R Baker
  • Victoria C Ridger
  • Simon DA Connell
  • Helen Philippou
  • Ramzi A Ajjan
  • Robert Ariens

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Jameel Iqbal, Icahn School of Medicine at Mount Sinai, United States

Ethics

Animal experimentation: Procedures were performed according to accepted standards of humane animal care, approved by the ethical review committee at the University of Leeds, and conducted under license (P144DD0D6) from the United Kingdom Home Office.

Version history

  1. Received: March 24, 2021
  2. Preprint posted: May 8, 2021 (view preprint)
  3. Accepted: October 4, 2021
  4. Accepted Manuscript published: October 11, 2021 (version 1)
  5. Accepted Manuscript updated: October 15, 2021 (version 2)
  6. Version of Record published: October 28, 2021 (version 3)
  7. Version of Record updated: January 7, 2022 (version 4)

Copyright

© 2021, McPherson et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,612
    views
  • 221
    downloads
  • 14
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Helen McPherson
  2. Cedric Duval
  3. Stephen R Baker
  4. Matthew S Hindle
  5. Lih T Cheah
  6. Nathan L Asquith
  7. Marco M Domingues
  8. Victoria C Ridger
  9. Simon DA Connell
  10. Khalid Naseem
  11. Helen Philippou
  12. Ramzi A Ajjan
  13. Robert AS Ariens
(2021)
Fibrinogen αC-subregions critically contribute blood clot fibre growth, mechanical stability and resistance to fibrinolysis
eLife 10:e68761.
https://doi.org/10.7554/eLife.68761

Share this article

https://doi.org/10.7554/eLife.68761

Further reading

    1. Cell Biology
    2. Stem Cells and Regenerative Medicine
    Rajdeep Banerjee, Thomas J Meyer ... David D Roberts
    Research Article

    Extramedullary erythropoiesis is not expected in healthy adult mice, but erythropoietic gene expression was elevated in lineage-depleted spleen cells from Cd47−/− mice. Expression of several genes associated with early stages of erythropoiesis was elevated in mice lacking CD47 or its signaling ligand thrombospondin-1, consistent with previous evidence that this signaling pathway inhibits expression of multipotent stem cell transcription factors in spleen. In contrast, cells expressing markers of committed erythroid progenitors were more abundant in Cd47−/− spleens but significantly depleted in Thbs1−/− spleens. Single-cell transcriptome and flow cytometry analyses indicated that loss of CD47 is associated with accumulation and increased proliferation in spleen of Ter119CD34+ progenitors and Ter119+CD34 committed erythroid progenitors with elevated mRNA expression of Kit, Ermap, and Tfrc. Induction of committed erythroid precursors is consistent with the known function of CD47 to limit the phagocytic removal of aged erythrocytes. Conversely, loss of thrombospondin-1 delays the turnover of aged red blood cells, which may account for the suppression of committed erythroid precursors in Thbs1−/− spleens relative to basal levels in wild-type mice. In addition to defining a role for CD47 to limit extramedullary erythropoiesis, these studies reveal a thrombospondin-1-dependent basal level of extramedullary erythropoiesis in adult mouse spleen.

    1. Cell Biology
    Makiko Kashio, Sandra Derouiche ... Makoto Tominaga
    Research Article

    Reports indicate that an interaction between TRPV4 and anoctamin 1 (ANO1) could be widely involved in water efflux of exocrine glands, suggesting that the interaction could play a role in perspiration. In secretory cells of sweat glands present in mouse foot pads, TRPV4 clearly colocalized with cytokeratin 8, ANO1, and aquaporin-5 (AQP5). Mouse sweat glands showed TRPV4-dependent cytosolic Ca2+ increases that were inhibited by menthol. Acetylcholine-stimulated sweating in foot pads was temperature-dependent in wild-type, but not in TRPV4-deficient mice and was inhibited by menthol both in wild-type and TRPM8KO mice. The basal sweating without acetylcholine stimulation was inhibited by an ANO1 inhibitor. Sweating could be important for maintaining friction forces in mouse foot pads, and this possibility is supported by the finding that wild-type mice climbed up a slippery slope more easily than TRPV4-deficient mice. Furthermore, TRPV4 expression was significantly higher in controls and normohidrotic skin from patients with acquired idiopathic generalized anhidrosis (AIGA) compared to anhidrotic skin from patients with AIGA. Collectively, TRPV4 is likely involved in temperature-dependent perspiration via interactions with ANO1, and TRPV4 itself or the TRPV4/ANO 1 complex would be targeted to develop agents that regulate perspiration.